Becamex Pharmaceutical Joint Stock Co (Becamex Pharma) planned to achieve its targeted 2009 turnover of 132.12 billion dong, pre-tax profit of 6.1 billion dong and EPS of 1,510 dong.
The company’s chartered capital in 2009 would be increased from 40.4 billion dong to 80.8 billion dong via issuing additional shares for the current shareholders with the rate of 1:1
Becamex Pharma’s revenue last year was recorded at 89.170 billion dong, after-tax profit of 5.919 billion dong.
The company is located at NA6, My Phuoc 2 Industrial zone, Ben Cat district, Binh Duong province. Its main business lines now is manufacturing and trading medicine, health materials and cosmetics.